Early treatment of slow-growing brain tumors may worsen cognitive function
The treatment of a slow-growing brain tumor is often accompanied by impaired cognitive functions such as difficulties with…
Hematological and biochemical indicators show growing value in breast cancer management
Breast cancer remains a predominant global health challenge for women, with late-stage diagnosis being a key contributor to…
Inflammatory biomarkers offer new insights for precision medicine in ischemic stroke
Ischemic stroke, a leading cause of disability and mortality worldwide, is a complex cerebrovascular event with outcomes heavily…
RNA-based cocktail shows promise against glioblastoma
A patented RNA-based cocktail developed at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has emerged as…
Stereotactic radiosurgery for craniopharyngioma management
Craniopharyngiomas account for 2–5% of all primary brain tumors and 5–10% of pediatric brain tumors. Despite their benign…
New NIH grants support research on how brain fluid movement drives glioblastoma spread
Jennifer Munson, a cancer researcher at Virginia Tech’s Fralin Biomedical Research Institute at VTC, has been awarded two new…
Neoantigens-loaded DC vaccines show strong potential to overcome tumor resistance
Despite the success of immune checkpoint inhibitors in revolutionizing oncology, their benefits remain limited to a small fraction…
Blocking mir-21 shows promise for slowing bladder cancer growth
Bladder cancer ranks among the ten most common types of cancer worldwide. The main treatment is bladder removal…
Breast cancer cells use a molecular switch to survive stress
Cells are regularly faced with environmental stresses that may damage or destroy them. To survive, they quickly adjust…
Unexpected traces of bacteria found within brain tumors
Researchers at The University of Texas MD Anderson Cancer Center have uncovered unexpected traces of bacteria within brain…
Innovative research reveals FGD3 as a key player in breast cancer cell death
A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the…
GLP-1 drugs linked to improved survival in colon cancer patients
A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists –…